首页 > 最新文献

Maedica最新文献

英文 中文
Neoadjuvant Chemotherapy: Friend or Foe. 新辅助化疗:是敌是友。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.417
Cristian Nicolae Popa, Vladimir Dan Bratu, Elisa Cristina Popa, Daniela Elena Dinu, Cristina Iosif, Evelina Chirita, Ioan Nicolae Mates

Introduction: Most breast cancers require neoadjuvant chemotherapy and the response to primary systemic therapy (PST) is crucial for deciding on the surgical technique and predicting patient outcomes. However, chemotherapy also brings numerous side effects, with cardiovascular issues being some of the most significant, common and challenging to manage.

Case presentation: We present the case of a 71-year-old woman diagnosed with stage T2N1M0 Luminal B breast cancer. It was decided to initiate chemotherapy consisting of four cycles of FEC (5-fluorouracil 600 mg/m² on days 1 and 8, epirubicin 60 mg-90 mg/m² and cyclophosphamide 600 mg/m²), followed by four cycles of docetaxel (75 mg/m² every three weeks). Near the end of the treatment cycles, she developed new-onset angina with complex critical coronary lesions. This required assembling a multidisciplinary team to determine the optimal management strategy from cardiological, surgical, and oncological standpoints. Just when we thought we had found the optimal approach for managing ischemic heart disease, the situation became more complicated with the development of deep vein thrombosis, requiring a reassessment of the entire treatment plan.

Conclusions: Neoadjuvant chemotherapy is an important weapon against breast cancer but also a veritable enemy of cardiovascular diseases. The association of two major diseases requires a multidisciplinary team capable of making the best decisions to maximize benefits and minimize adverse effects.

简介大多数乳腺癌都需要进行新辅助化疗,对主要系统治疗(PST)的反应对于决定手术技术和预测患者预后至关重要。然而,化疗也会带来许多副作用,其中心血管问题是最重要、最常见和最难处理的副作用之一:我们介绍了一位 71 岁女性的病例,她被诊断为 T2N1M0 Luminal B 期乳腺癌。化疗包括四个周期的 FEC(5-氟尿嘧啶 600 mg/m²,第 1 天和第 8 天;表柔比星 60 mg-90 mg/m²;环磷酰胺 600 mg/m²),随后是四个周期的多西他赛(75 mg/m²,每三周一次)。治疗周期快结束时,她出现了新发心绞痛,并伴有复杂的危重冠状动脉病变。这需要组建一个多学科团队,从心脏病学、外科和肿瘤学的角度确定最佳治疗策略。就在我们以为找到了治疗缺血性心脏病的最佳方法时,情况却因为深静脉血栓的形成而变得更加复杂,需要重新评估整个治疗方案:结论:新辅助化疗是抗击乳腺癌的重要武器,同时也是心血管疾病名副其实的大敌。两种主要疾病的结合需要一个多学科团队,能够做出最佳决策,最大限度地提高疗效,减少不良反应。
{"title":"Neoadjuvant Chemotherapy: Friend or Foe.","authors":"Cristian Nicolae Popa, Vladimir Dan Bratu, Elisa Cristina Popa, Daniela Elena Dinu, Cristina Iosif, Evelina Chirita, Ioan Nicolae Mates","doi":"10.26574/maedica.2024.19.2.417","DOIUrl":"10.26574/maedica.2024.19.2.417","url":null,"abstract":"<p><strong>Introduction: </strong>Most breast cancers require neoadjuvant chemotherapy and the response to primary systemic therapy (PST) is crucial for deciding on the surgical technique and predicting patient outcomes. However, chemotherapy also brings numerous side effects, with cardiovascular issues being some of the most significant, common and challenging to manage.</p><p><strong>Case presentation: </strong>We present the case of a 71-year-old woman diagnosed with stage T2N1M0 Luminal B breast cancer. It was decided to initiate chemotherapy consisting of four cycles of FEC (5-fluorouracil 600 mg/m² on days 1 and 8, epirubicin 60 mg-90 mg/m² and cyclophosphamide 600 mg/m²), followed by four cycles of docetaxel (75 mg/m² every three weeks). Near the end of the treatment cycles, she developed new-onset angina with complex critical coronary lesions. This required assembling a multidisciplinary team to determine the optimal management strategy from cardiological, surgical, and oncological standpoints. Just when we thought we had found the optimal approach for managing ischemic heart disease, the situation became more complicated with the development of deep vein thrombosis, requiring a reassessment of the entire treatment plan.</p><p><strong>Conclusions: </strong>Neoadjuvant chemotherapy is an important weapon against breast cancer but also a veritable enemy of cardiovascular diseases. The association of two major diseases requires a multidisciplinary team capable of making the best decisions to maximize benefits and minimize adverse effects.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Center Experience of Genetic Testing in Patients Undergoing Breast Cancer Treatment. 对接受乳腺癌治疗的患者进行基因检测的单中心经验。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.239
Laura Mihaela Mustata, Gheorghe Peltecu, Diana Cezara Mugescu, Florina Mihaela Nedelea, Mircea Dragos Median

Background: Breast cancer remains the most frequently diagnosed cancer in female population worldwide. However, germline mutations are responsible for a small proportion of these cases. The aim of our study is to assess how germline mutations influence the management and outcome of these patients taken into consideration both their cancer diagnosis and genetic assessment.

Methods: We performed a retrospective analysis in a women's single-center during a period of six years to assess the contribution of germline mutation in the treatment, prognosis and survival of breast cancer patients. Statistics were collected from both the patients' medical records and genetics department.

Results: From the total number of patients treated for breast cancer in our department between 2017 and 2022, 243 were eligible for genetic testing, comprising either BRCA1/2 or extended panel, taking into consideration their personal and family history. Of all subjects included in our study cohort, 5% were carriers of a pathogenic(P) or likely pathogenic(LP) variant of cancer susceptibility gene, of which 78% were diagnosed before the age of 50; triple negative disease was diagnosed in the majority of cases, and therefore, 62% of patients started treatment with systemic neoadjuvant chemotherapy and 32% of subjects underwent upfront surgery. Prophylactic surgery for contralateral breast and bilateral salpingo-oophorectomy was considered and performed for 20% of patients. Less than 2% of cases had metastatic disease and received PARP inhibitors, with excellent treatment response and a very low rate of mortality in the study group.

Conclusion: Carriers of pathogenic variants with breast cancer diagnosis may have a greater benefit from a tailored approach, including both surgical and oncological treatment, with better long-term outcomes.

背景:乳腺癌仍然是全球女性中最常确诊的癌症。然而,在这些病例中,种系突变只占一小部分。我们的研究旨在评估种系突变如何影响这些患者的治疗和预后,同时考虑到他们的癌症诊断和基因评估:方法:我们在一家女性单中心进行了一项为期六年的回顾性分析,以评估种系突变对乳腺癌患者的治疗、预后和生存的影响。统计资料来自患者病历和遗传学部门:2017年至2022年期间,在我院接受治疗的乳腺癌患者总数中,有243人符合基因检测条件,包括BRCA1/2或扩展面板,并考虑了他们的个人和家族病史。在纳入研究队列的所有受试者中,5%是癌症易感基因致病(P)或可能致病(LP)变异的携带者,其中78%在50岁之前确诊;大多数病例确诊为三阴性疾病,因此62%的患者开始接受全身新辅助化疗治疗,32%的受试者接受了前期手术治疗。20%的患者考虑并接受了对侧乳房预防性手术和双侧输卵管切除术。不到 2% 的病例患有转移性疾病,接受了 PARP 抑制剂治疗,治疗反应良好,研究组的死亡率非常低:结论:确诊为乳腺癌的致病变异携带者可从包括手术和肿瘤治疗在内的定制方法中获益更多,长期疗效更好。
{"title":"Single Center Experience of Genetic Testing in Patients Undergoing Breast Cancer Treatment.","authors":"Laura Mihaela Mustata, Gheorghe Peltecu, Diana Cezara Mugescu, Florina Mihaela Nedelea, Mircea Dragos Median","doi":"10.26574/maedica.2024.19.2.239","DOIUrl":"10.26574/maedica.2024.19.2.239","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer remains the most frequently diagnosed cancer in female population worldwide. However, germline mutations are responsible for a small proportion of these cases. The aim of our study is to assess how germline mutations influence the management and outcome of these patients taken into consideration both their cancer diagnosis and genetic assessment.</p><p><strong>Methods: </strong>We performed a retrospective analysis in a women's single-center during a period of six years to assess the contribution of germline mutation in the treatment, prognosis and survival of breast cancer patients. Statistics were collected from both the patients' medical records and genetics department.</p><p><strong>Results: </strong>From the total number of patients treated for breast cancer in our department between 2017 and 2022, 243 were eligible for genetic testing, comprising either BRCA1/2 or extended panel, taking into consideration their personal and family history. Of all subjects included in our study cohort, 5% were carriers of a pathogenic(P) or likely pathogenic(LP) variant of cancer susceptibility gene, of which 78% were diagnosed before the age of 50; triple negative disease was diagnosed in the majority of cases, and therefore, 62% of patients started treatment with systemic neoadjuvant chemotherapy and 32% of subjects underwent upfront surgery. Prophylactic surgery for contralateral breast and bilateral salpingo-oophorectomy was considered and performed for 20% of patients. Less than 2% of cases had metastatic disease and received PARP inhibitors, with excellent treatment response and a very low rate of mortality in the study group.</p><p><strong>Conclusion: </strong>Carriers of pathogenic variants with breast cancer diagnosis may have a greater benefit from a tailored approach, including both surgical and oncological treatment, with better long-term outcomes.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Dose or Low-Dose Corticosteroids - Which Regimen is More Effective in Patients with Moderate to Severe COVID-19? A Retrospective Study. 大剂量或小剂量皮质类固醇--哪种方案对中度至重度 COVID-19 患者更有效?一项回顾性研究。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.330
Alireza Kashefizadeh, Farbod Amiri, Laya Ohadi, Elham Keikha

Background: Although several studies have assessed corticosteroid therapy as a pivotal treatment for SARS-CoV-2, the net effectiveness of corticosteroids in the treatment of COVID-19 remains controversial. This study aimed to compare the conventional use of methylprednisolone and pulse therapy to determine the best method of administration of corticosteroids in patients with SARS-CoV-2.

Methods: A total of 52 patients with a diagnosis of moderate to severe COVID-19 with the same conditions were retrospectively enrolled in the present study. Participants were divided into two groups based on the corticosteroid therapy regimen received during hospitalization: low-dose and high-dose methylprednisolone. Clinical outcomes, including laboratory tests, improvement of oxygen saturation, the need for invasive mechanical ventilation, length of hospital stay (LOHS) and mortality, were compared between the two groups.

Results: The distribution of sex, age, oxygen saturation on admission, pattern and location of lung involvement, and other medical conditions were similar between the two groups to avoid the effect of any possible confounding factor. There were no differences in laboratory tests (P=0.389), LOHS (P=0.107), improvement of oxygen saturation (P=0.721), the need for invasive mechanical ventilation and mortality (P=0.695) between groups.

Conclusion: Based on the results of this study, there was no significant difference in clinical outcomes of patients with COVID-19 between low- and high-dose corticosteroid regimens. Further research is warranted to determine the best method of administration of corticosteroids in these patients.

背景:尽管多项研究已将皮质类固醇疗法作为治疗SARS-CoV-2的关键疗法进行了评估,但皮质类固醇治疗COVID-19的净效果仍存在争议。本研究旨在比较甲基强的松龙和脉冲疗法的常规使用方法,以确定对 SARS-CoV-2 患者使用皮质类固醇的最佳方法:本研究回顾性地纳入了 52 名诊断为中度至重度 COVID-19 且病情相同的患者。根据住院期间接受的皮质类固醇治疗方案将参与者分为两组:小剂量和大剂量甲基强的松龙。比较了两组患者的临床结果,包括实验室检查、血氧饱和度改善情况、有创机械通气需求、住院时间(LOHS)和死亡率:两组患者的性别、年龄、入院时血氧饱和度、肺部受累模式和部位以及其他病症的分布情况相似,从而避免了任何可能的混杂因素的影响。两组患者在实验室检查(P=0.389)、LOHS(P=0.107)、血氧饱和度改善(P=0.721)、有创机械通气需求和死亡率(P=0.695)方面均无差异:根据本研究的结果,低剂量和高剂量皮质类固醇治疗方案对 COVID-19 患者的临床疗效无明显差异。有必要开展进一步研究,以确定这些患者使用皮质类固醇的最佳方法。
{"title":"High-Dose or Low-Dose Corticosteroids - Which Regimen is More Effective in Patients with Moderate to Severe COVID-19? A Retrospective Study.","authors":"Alireza Kashefizadeh, Farbod Amiri, Laya Ohadi, Elham Keikha","doi":"10.26574/maedica.2024.19.2.330","DOIUrl":"10.26574/maedica.2024.19.2.330","url":null,"abstract":"<p><strong>Background: </strong>Although several studies have assessed corticosteroid therapy as a pivotal treatment for SARS-CoV-2, the net effectiveness of corticosteroids in the treatment of COVID-19 remains controversial. This study aimed to compare the conventional use of methylprednisolone and pulse therapy to determine the best method of administration of corticosteroids in patients with SARS-CoV-2.</p><p><strong>Methods: </strong>A total of 52 patients with a diagnosis of moderate to severe COVID-19 with the same conditions were retrospectively enrolled in the present study. Participants were divided into two groups based on the corticosteroid therapy regimen received during hospitalization: low-dose and high-dose methylprednisolone. Clinical outcomes, including laboratory tests, improvement of oxygen saturation, the need for invasive mechanical ventilation, length of hospital stay (LOHS) and mortality, were compared between the two groups.</p><p><strong>Results: </strong>The distribution of sex, age, oxygen saturation on admission, pattern and location of lung involvement, and other medical conditions were similar between the two groups to avoid the effect of any possible confounding factor. There were no differences in laboratory tests (P=0.389), LOHS (P=0.107), improvement of oxygen saturation (P=0.721), the need for invasive mechanical ventilation and mortality (P=0.695) between groups.</p><p><strong>Conclusion: </strong>Based on the results of this study, there was no significant difference in clinical outcomes of patients with COVID-19 between low- and high-dose corticosteroid regimens. Further research is warranted to determine the best method of administration of corticosteroids in these patients.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tocophobia: Risk Factors, Consequences and Management - A Systematic Review of the Literature. 恐高症:风险因素、后果和管理--文献系统回顾。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.393
Angeliki Sarella, Sofoklis Stavros, Giannoula Kirkou, Maria Iliadou, Eriketi Kokkosi, Anastasia Bothou, Eirini Chasalevri, Victoria Vivilaki, Eleni Tsotra

Objective: As far as childbirth is concerned, it is well known that it constitutes a major life process for every woman. Many women experience negative emotions during pregnancy because of the normal hormonal changes. However, if fear becomes severe, it gives rise to a specific pathology termed tocophobia. Especially, tocophobia adversely affects women's pregnancy and childbirth, including increased caesarean sections. Consequently, midwives need to detect women with tocophobia in order to support them. The aim of the present systematic review was to analyze the risk factors for tocophobia, the impact of this health condition on caesarean sections and the midwife's role.

Materials and methods: The present systematic review comprised 32 full-text cross-sectional, qualitative, experimental studies and cohort studies published in English between 2017 and 2022, that were obtained from PubMed and Google Scholar databases, and it was conducted according to the PRISMA guideline.

Results: The present analysis found that sociodemographic, obstetric and psychological factors were associated with tocophobia. Moreover, women with severe fear had increased obstetric interventions, particularly caesarean sections. Studies have also shown that psycho-education, preparation classes and specific counselling by trained midwives are effective methods in reducing tocophobia.

Conclusions: Midwives should be aware of the risk factors for tocophobia in order to detect women with fears and support them in the attempt to avoid non-urgent obstetric interventions. Antenatal and intrapartum care should be offered to women with tocophobia to reduce their fear as well as the prevalence of caesarean section and to promote vaginal birth with a positive experience.

目的:众所周知,分娩是每个妇女的一个重要生命过程。由于正常的荷尔蒙变化,许多妇女在怀孕期间会出现负面情绪。然而,如果恐惧变得严重,就会产生一种特殊的病理现象,即恐产症。尤其是,恐高症会对妇女的怀孕和分娩产生不利影响,包括增加剖腹产的次数。因此,助产士需要发现患有恐高症的妇女,以便为她们提供支持。本系统性综述旨在分析恐高症的风险因素、这种健康状况对剖腹产的影响以及助产士的作用:本系统综述包括从PubMed和谷歌学术数据库中获取的2017年至2022年间发表的32篇英文全文横断面、定性、实验研究和队列研究,并按照PRISMA指南进行:本分析发现,社会人口、产科和心理因素与恐高症有关。此外,患有严重恐高症的妇女会增加产科干预,尤其是剖腹产。研究还表明,由训练有素的助产士进行心理教育、准备课程和特定咨询是减少恐产症的有效方法:助产士应了解恐产症的风险因素,以便发现有恐产症的妇女,并为她们提供支持,避免非紧急产科干预。应为患有恐高症的妇女提供产前和产中护理,以减少她们的恐惧和剖腹产的发生率,并促进阴道分娩的积极体验。
{"title":"Tocophobia: Risk Factors, Consequences and Management - A Systematic Review of the Literature.","authors":"Angeliki Sarella, Sofoklis Stavros, Giannoula Kirkou, Maria Iliadou, Eriketi Kokkosi, Anastasia Bothou, Eirini Chasalevri, Victoria Vivilaki, Eleni Tsotra","doi":"10.26574/maedica.2024.19.2.393","DOIUrl":"10.26574/maedica.2024.19.2.393","url":null,"abstract":"<p><strong>Objective: </strong>As far as childbirth is concerned, it is well known that it constitutes a major life process for every woman. Many women experience negative emotions during pregnancy because of the normal hormonal changes. However, if fear becomes severe, it gives rise to a specific pathology termed tocophobia. Especially, tocophobia adversely affects women's pregnancy and childbirth, including increased caesarean sections. Consequently, midwives need to detect women with tocophobia in order to support them. The aim of the present systematic review was to analyze the risk factors for tocophobia, the impact of this health condition on caesarean sections and the midwife's role.</p><p><strong>Materials and methods: </strong>The present systematic review comprised 32 full-text cross-sectional, qualitative, experimental studies and cohort studies published in English between 2017 and 2022, that were obtained from PubMed and Google Scholar databases, and it was conducted according to the PRISMA guideline.</p><p><strong>Results: </strong>The present analysis found that sociodemographic, obstetric and psychological factors were associated with tocophobia. Moreover, women with severe fear had increased obstetric interventions, particularly caesarean sections. Studies have also shown that psycho-education, preparation classes and specific counselling by trained midwives are effective methods in reducing tocophobia.</p><p><strong>Conclusions: </strong>Midwives should be aware of the risk factors for tocophobia in order to detect women with fears and support them in the attempt to avoid non-urgent obstetric interventions. Antenatal and intrapartum care should be offered to women with tocophobia to reduce their fear as well as the prevalence of caesarean section and to promote vaginal birth with a positive experience.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Antibiotic Prevention of Catheter Mechanic and Septic Complications in Patients with Long-Term Indwelling Catheters: a Crossover Prospective Study Involving L-Methionine. 非抗生素预防长期留置导管患者的导管机械性并发症和化脓性并发症:一项涉及 L-Methionine 的交叉前瞻性研究。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.212
Aurel Rusu, Razvan-Ionut Popescu, Gabriel Predoiu, Razvan-Cosmin Petca, Alexandru Ciudin, Aida Petca, Justin Aurelian, Daniel Radavoi, Viorel Jinga

Bacterial antimicrobial resistance (AMR) is a major public health concern in modern society caused by bacterial changes that impair the efficacy of infection-treating drugs. Non-antibiotic techniques are critical for controlling the antimicrobial resistance concern because they provide a means of alleviating symptoms without needing antibiotics. This prospective study aims to determine whether administering L-methionine reduces mechanical and bacterial problems associated with long-term indwelling urinary catheters. The trial focused on administering only L-methionine for a three-month period to patients who had long-term bladder catheters, either indwelling or suprapubic. The catheter exchange rates were categorized according to acute urinary tract infection, macroscopic haematuria and symptomatic urinary tract infection. During the time of inclusion, catheter-related incidents were recorded. The primary incident observed was acute urine retention caused by catheter obstruction in 63.6.

细菌的抗菌药耐药性(AMR)是现代社会的一个主要公共卫生问题,它是由于细菌的变化损害了治疗感染药物的疗效而引起的。非抗生素技术是控制抗菌药耐药性的关键,因为它们提供了一种无需抗生素即可缓解症状的方法。这项前瞻性研究旨在确定使用 L-蛋氨酸是否能减少与长期留置导尿管相关的机械和细菌问题。试验的重点是在三个月的时间内只给长期使用留置导尿管或耻骨上导尿管的患者注射 L-蛋氨酸。导尿管更换率根据急性尿路感染、大面积血尿和无症状尿路感染进行分类。在纳入研究期间,对导尿管相关事件进行了记录。观察到的主要事故是导尿管阻塞导致的急性尿潴留,占 63.6%。
{"title":"Non-Antibiotic Prevention of Catheter Mechanic and Septic Complications in Patients with Long-Term Indwelling Catheters: a Crossover Prospective Study Involving L-Methionine.","authors":"Aurel Rusu, Razvan-Ionut Popescu, Gabriel Predoiu, Razvan-Cosmin Petca, Alexandru Ciudin, Aida Petca, Justin Aurelian, Daniel Radavoi, Viorel Jinga","doi":"10.26574/maedica.2024.19.2.212","DOIUrl":"10.26574/maedica.2024.19.2.212","url":null,"abstract":"<p><p>Bacterial antimicrobial resistance (AMR) is a major public health concern in modern society caused by bacterial changes that impair the efficacy of infection-treating drugs. Non-antibiotic techniques are critical for controlling the antimicrobial resistance concern because they provide a means of alleviating symptoms without needing antibiotics. This prospective study aims to determine whether administering L-methionine reduces mechanical and bacterial problems associated with long-term indwelling urinary catheters. The trial focused on administering only L-methionine for a three-month period to patients who had long-term bladder catheters, either indwelling or suprapubic. The catheter exchange rates were categorized according to acute urinary tract infection, macroscopic haematuria and symptomatic urinary tract infection. During the time of inclusion, catheter-related incidents were recorded. The primary incident observed was acute urine retention caused by catheter obstruction in 63.6.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pleomorphic Adenoma of Minor Salivary Glands: a Rare Case Report. 小唾液腺多形性腺瘤:一例罕见病例报告。
Pub Date : 2024-06-01 DOI: 10.26574/maedica.2024.19.2.434
Aikaterini D Lianou, Athina Zarachi, Spyridoula Derka, Chrissa Sioka, Napoleon-Georgios Ragkos, Angelos Liontos, Evangelos Tsiambas, Asimakis Asimakopoulos, Vasileios Ragos

Pleomorphic adenoma is a non-cancerous neoplasm that develops in the salivary glands. Originating from minor salivary glands, it is extremely uncommon and primarily affects females. The peak incidence is observed between 40 and 60 years of age. It usually presents as a slowly growing, painless, solid tumor that does not cause ulcers on the overlying mucosa. Here, a 47-year-old woman experienced repeated swelling on the buccal mucosa following surgical extraction of a pleomorphic adenoma three years ago. The swelling was solid with clearly defined boundaries. An excisional biopsy was conducted under general anesthesia, resulting in total mass removal. The histological evaluation revealed the existence of a recurring pleomorphic adenoma. This instance emphasizes the significance of addressing this entity as a potential etiology for persistent painless and intraoral swellings.

多形性腺瘤是一种发生在唾液腺中的非癌症肿瘤。它起源于小唾液腺,极为罕见,主要影响女性。发病高峰在 40 至 60 岁之间。它通常表现为生长缓慢、无痛的实性肿瘤,不会引起上覆黏膜溃疡。这里有一名 47 岁的女性,三年前手术摘除多形性腺瘤后,口腔黏膜反复肿胀。肿物为实性,边界清晰。在全身麻醉下进行了切除活检,结果肿块被完全切除。组织学评估显示,这是一个复发性多形性腺瘤。这一病例强调了将这一实体作为持续性无痛和口腔内肿物的潜在病因进行处理的重要性。
{"title":"Pleomorphic Adenoma of Minor Salivary Glands: a Rare Case Report.","authors":"Aikaterini D Lianou, Athina Zarachi, Spyridoula Derka, Chrissa Sioka, Napoleon-Georgios Ragkos, Angelos Liontos, Evangelos Tsiambas, Asimakis Asimakopoulos, Vasileios Ragos","doi":"10.26574/maedica.2024.19.2.434","DOIUrl":"10.26574/maedica.2024.19.2.434","url":null,"abstract":"<p><p>Pleomorphic adenoma is a non-cancerous neoplasm that develops in the salivary glands. Originating from minor salivary glands, it is extremely uncommon and primarily affects females. The peak incidence is observed between 40 and 60 years of age. It usually presents as a slowly growing, painless, solid tumor that does not cause ulcers on the overlying mucosa. Here, a 47-year-old woman experienced repeated swelling on the buccal mucosa following surgical extraction of a pleomorphic adenoma three years ago. The swelling was solid with clearly defined boundaries. An excisional biopsy was conducted under general anesthesia, resulting in total mass removal. The histological evaluation revealed the existence of a recurring pleomorphic adenoma. This instance emphasizes the significance of addressing this entity as a potential etiology for persistent painless and intraoral swellings.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleeve Gastrectomy: Literature Results. 袖状胃切除术:文献结果。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2021.19.1.137
Silvana Leanza, Danilo Coco, Massimo Giuseppee Viola

Sleeve gastrectomy (SG) is the most frequently performed bariatric procedure globally. However, data regarding short- and long-term results remain insufficient. This study aimed to evaluate the short- and longterm effects of SG. We performed a thorough PubMed search for references that mentioned sleeve gastrectomy was carried out. In terms of weight loss and resolution of comorbid disorders, the immediate results have been encouraging. Although long-term results are still being obtained, a large number of individuals have experienced persistent weight loss. Eight short-term studies were extracted for the present review. Each study clarified that SG was utilized as a management technique for a high-risk patient population or as a component of a stepwise therapeutic procedure. The laparoscopic SG method was examined in all studies. The percentage of patients who were followed up for 30 days or longer after LSG was reported. Significant weight loss has been observed in studies that evaluated short-term results. An excess weight loss of 67.3% and a significant decrease in body mass index (BMI) were observed in a systematic evaluation of 5,218 patients. In long-term studies, SG was administered to 2713 patients, of whom 1626 completed the five-year follow-up period. Among all patients, 71.3% were women and 28.7% men. The mean BMI before surgery was 46.9 kg/m². The follow-up durations ranged from 5 to 11 years. The mean five-year follow-up rate was 66% (range 57-100%). At 5, 6, 7, 8 and 11 years, the mean percentage excess weight decreases were 58.4%, 59.5%, 56.6% and 62.5%, respectively. Five years after SG, resolution of type 2 diabetes resolved in 77.8% of patients, and arterial hypertension, dyslipidemia, obstructive sleep apnea, gastroesophageal reflux disease and degenerative joint diseases improved or resolved in 68.0%, 65.9%, 75.8%, 30.6% and 55.7% of patients, respectively. Laparoscopic SG is more technically straightforward and has fewer surgical complications than other more complex surgical techniques. Laparoscopic SG is an effective treatment option for bariatric surgery. It is relatively easy to perform, well tolerated by patients and effective for longterm excessive weight loss and resolution of comorbidities.

袖带胃切除术(SG)是全球最常见的减肥手术。然而,有关短期和长期效果的数据仍然不足。本研究旨在评估袖带胃切除术的短期和长期效果。我们在 PubMed 上对提及袖带胃切除术的参考文献进行了全面搜索。就体重减轻和合并症的缓解而言,近期效果令人鼓舞。虽然长期结果仍在取得中,但许多人的体重持续下降。本综述摘录了八项短期研究。每项研究都明确指出,SG 是作为一种管理技术用于高风险患者群体,或作为阶梯治疗程序的一个组成部分。所有研究都采用了腹腔镜 SG 方法。报告了在 LSG 术后随访 30 天或更长时间的患者比例。在评估短期结果的研究中,观察到体重明显减轻。在一项对 5,218 名患者进行的系统评估中,观察到体重超额下降了 67.3%,体重指数(BMI)也显著下降。在长期研究中,有 2713 名患者接受了 SG 治疗,其中有 1626 人完成了为期五年的随访。在所有患者中,女性占 71.3%,男性占 28.7%。手术前的平均体重指数为 46.9 kg/m²。随访时间从 5 年到 11 年不等。平均五年随访率为 66%(范围为 57-100%)。5年、6年、7年、8年和11年的平均超重下降率分别为58.4%、59.5%、56.6%和62.5%。腹腔镜手术 5 年后,77.8% 的患者 2 型糖尿病得到缓解,68.0%、65.9%、75.8%、30.6% 和 55.7% 的患者动脉高血压、血脂异常、阻塞性睡眠呼吸暂停、胃食管反流病和退行性关节疾病得到改善或缓解。与其他更复杂的手术技术相比,腹腔镜 SG 技术更简单,手术并发症更少。腹腔镜 SG 是减肥手术的有效治疗方案。腹腔镜 SG 手术操作相对简单,患者耐受性好,对长期过度减肥和消除合并症有效。
{"title":"Sleeve Gastrectomy: Literature Results.","authors":"Silvana Leanza, Danilo Coco, Massimo Giuseppee Viola","doi":"10.26574/maedica.2021.19.1.137","DOIUrl":"10.26574/maedica.2021.19.1.137","url":null,"abstract":"<p><p>Sleeve gastrectomy (SG) is the most frequently performed bariatric procedure globally. However, data regarding short- and long-term results remain insufficient. This study aimed to evaluate the short- and longterm effects of SG. We performed a thorough PubMed search for references that mentioned sleeve gastrectomy was carried out. In terms of weight loss and resolution of comorbid disorders, the immediate results have been encouraging. Although long-term results are still being obtained, a large number of individuals have experienced persistent weight loss. Eight short-term studies were extracted for the present review. Each study clarified that SG was utilized as a management technique for a high-risk patient population or as a component of a stepwise therapeutic procedure. The laparoscopic SG method was examined in all studies. The percentage of patients who were followed up for 30 days or longer after LSG was reported. Significant weight loss has been observed in studies that evaluated short-term results. An excess weight loss of 67.3% and a significant decrease in body mass index (BMI) were observed in a systematic evaluation of 5,218 patients. In long-term studies, SG was administered to 2713 patients, of whom 1626 completed the five-year follow-up period. Among all patients, 71.3% were women and 28.7% men. The mean BMI before surgery was 46.9 kg/m². The follow-up durations ranged from 5 to 11 years. The mean five-year follow-up rate was 66% (range 57-100%). At 5, 6, 7, 8 and 11 years, the mean percentage excess weight decreases were 58.4%, 59.5%, 56.6% and 62.5%, respectively. Five years after SG, resolution of type 2 diabetes resolved in 77.8% of patients, and arterial hypertension, dyslipidemia, obstructive sleep apnea, gastroesophageal reflux disease and degenerative joint diseases improved or resolved in 68.0%, 65.9%, 75.8%, 30.6% and 55.7% of patients, respectively. Laparoscopic SG is more technically straightforward and has fewer surgical complications than other more complex surgical techniques. Laparoscopic SG is an effective treatment option for bariatric surgery. It is relatively easy to perform, well tolerated by patients and effective for longterm excessive weight loss and resolution of comorbidities.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Effect of Silver Diamine Fluoride, with or without Glutathione and Potassium Iodide, on Fluoride Release, Dentin Microhardness and Surface Properties of Dentin. 评估含或不含谷胱甘肽和碘化钾的二卤化氟化银对氟化物释放、牙本质微硬度和牙本质表面特性的影响
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.48
Mahsa Samani, Sanaz Alimirzaei, Azita Kaviani, Faramarz Zakavi

This study aimed to evaluate the effect of silver diamine fluoride (SDF) in combination with or without glutathione (Glu) and potassium iodide (KI) on the fluoride release and the enhancement of dentin microhardness. In this et al study, 90 intact premolar teeth from human subjects were allocated into nine groups, each consisting of ten samples: A) control; B) SDF; C) SDF combined with 5% Glu; D) SDF combined with 10% Glu; E) SDF combined with 20% Glu; F) KI after SDF; G) 5% Glu after SDF; H) 10% Glu after SDF; and I) 20% Glu after SDF. Data were analyzed using SPSS version 22 software and ANOVA and post-hoc and repeated measure test (P value <0.05). Dentin microhardness exhibited variations across different treatments, with the highest value being observed in the SDF-5% Glu group and the lowest in the control group. However, there was a significant difference between the mean values of SDF-5% Glu group and the SDF group. Significant increases in microhardness were observed when comparing SDF-5% Glu to SDF+5% Glu and SDF-10% Glu to SDF+10% Glu in peer groups (P value <0.05). Over time, there was a significant increase in the amount of fluoride released as compared to the initial day. The utilization of SDF-5% Glu group exhibited the most favorable effect on improving dentin hardness. Additionally, utilizing Glu in concentrations of 5% and 10% after SDF application proved more effective in increasing dentin microhardness than combining it with SDF. Moreover, in all three fluoride measurement periods, adding 5% Glu to SDF and using 20% Glu following SDF administration led to a significant increase in fluoride release compared to the application of SDF alone.

本研究旨在评估二胺氟化银(SDF)与谷胱甘肽(Glu)和碘化钾(KI)结合或不结合对氟化物释放和牙本质微硬度增强的影响。在这项研究中,90 颗完整的人类前臼齿被分为九组,每组十个样本:A) 对照组;B) SDF 组;C) SDF 结合 5% Glu 组;D) SDF 结合 10% Glu 组;E) SDF 结合 20% Glu 组;F) SDF 后的 KI 组;G) SDF 后的 5% Glu 组;H) SDF 后的 10% Glu 组;I) SDF 后的 20% Glu 组。数据采用 SPSS 22 版软件进行分析,并进行方差分析和事后及重复测量检验(P 值为 0.05)。
{"title":"Evaluating the Effect of Silver Diamine Fluoride, with or without Glutathione and Potassium Iodide, on Fluoride Release, Dentin Microhardness and Surface Properties of Dentin.","authors":"Mahsa Samani, Sanaz Alimirzaei, Azita Kaviani, Faramarz Zakavi","doi":"10.26574/maedica.2024.19.1.48","DOIUrl":"10.26574/maedica.2024.19.1.48","url":null,"abstract":"<p><p>This study aimed to evaluate the effect of silver diamine fluoride (SDF) in combination with or without glutathione (Glu) and potassium iodide (KI) on the fluoride release and the enhancement of dentin microhardness. In this <i>et al</i> study, 90 intact premolar teeth from human subjects were allocated into nine groups, each consisting of ten samples: A) control; B) SDF; C) SDF combined with 5% Glu; D) SDF combined with 10% Glu; E) SDF combined with 20% Glu; F) KI after SDF; G) 5% Glu after SDF; H) 10% Glu after SDF; and I) 20% Glu after SDF. Data were analyzed using SPSS version 22 software and ANOVA and post-hoc and repeated measure test (P value <0.05). Dentin microhardness exhibited variations across different treatments, with the highest value being observed in the SDF-5% Glu group and the lowest in the control group. However, there was a significant difference between the mean values of SDF-5% Glu group and the SDF group. Significant increases in microhardness were observed when comparing SDF-5% Glu to SDF+5% Glu and SDF-10% Glu to SDF+10% Glu in peer groups (P value <0.05). Over time, there was a significant increase in the amount of fluoride released as compared to the initial day. The utilization of SDF-5% Glu group exhibited the most favorable effect on improving dentin hardness. Additionally, utilizing Glu in concentrations of 5% and 10% after SDF application proved more effective in increasing dentin microhardness than combining it with SDF. Moreover, in all three fluoride measurement periods, adding 5% Glu to SDF and using 20% Glu following SDF administration led to a significant increase in fluoride release compared to the application of SDF alone.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Mechanisms of Biofilm Formation on Orthopaedic Implants: Review of the Literature. 骨科植入物上生物膜形成的分子机制:文献综述
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2021.19.1.129
Matthaios Bakalakos, Margarita-Michaela Ampadiotaki, Christos Vlachos, Nikolaos Sipsas, Spiros Pneumaticos, John Vlamis

Orthopaedic implant-associated infections (OIAIs) is one of the most catastrophic complications following joint arthroplasty or fracture fixation. Given the increasing number of orthopaedic implants which are used annually, periprosthetic infections emerge as a global problem. Their diagnosis and consequent therapeutic management remain challenging for clinicians. Biofilm formation is a complex and only partially understood process that has not been extensively studied. Understanding the underlying mechanisms involved in biofilm formation is crucial in the amelioration of both diagnosis and therapeutic management of OIAIs. We performed a literature review of the molecular mechanisms of biofilm formation and discussed the four most common and thoroughly researched microbes of biofilm-related OIAIs.

骨科植入物相关感染(OIAIs)是关节置换术或骨折固定术后最严重的并发症之一。鉴于每年使用的骨科植入物数量不断增加,假体周围感染已成为一个全球性问题。对临床医生来说,假体周围感染的诊断和随之而来的治疗管理仍然具有挑战性。生物膜的形成是一个复杂的过程,目前还没有对其进行广泛的研究。了解生物膜形成的基本机制对于改善 OIAIs 的诊断和治疗管理至关重要。我们对生物膜形成的分子机制进行了文献综述,并讨论了四种最常见、研究最深入的生物膜相关 OIAI 微生物。
{"title":"Molecular Mechanisms of Biofilm Formation on Orthopaedic Implants: Review of the Literature.","authors":"Matthaios Bakalakos, Margarita-Michaela Ampadiotaki, Christos Vlachos, Nikolaos Sipsas, Spiros Pneumaticos, John Vlamis","doi":"10.26574/maedica.2021.19.1.129","DOIUrl":"10.26574/maedica.2021.19.1.129","url":null,"abstract":"<p><p>Orthopaedic implant-associated infections (OIAIs) is one of the most catastrophic complications following joint arthroplasty or fracture fixation. Given the increasing number of orthopaedic implants which are used annually, periprosthetic infections emerge as a global problem. Their diagnosis and consequent therapeutic management remain challenging for clinicians. Biofilm formation is a complex and only partially understood process that has not been extensively studied. Understanding the underlying mechanisms involved in biofilm formation is crucial in the amelioration of both diagnosis and therapeutic management of OIAIs. We performed a literature review of the molecular mechanisms of biofilm formation and discussed the four most common and thoroughly researched microbes of biofilm-related OIAIs.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Value of MRI Compared to Histopathological Results in Differentiating Benign from Malignant Ovarian Masses. 核磁共振成像与组织病理学结果相比在区分良性与恶性卵巢肿块方面的诊断价值。
Pub Date : 2024-03-01 DOI: 10.26574/maedica.2024.19.1.4
Azamsadat Jalili, Narges Afzali

Introduction and aim: Ovarian cancer is a prevalent neoplastic condition among females. Early diagnosis is essential in improving patient outcomes. This study aimed to determine the diagnostic value of magnetic resonance imaging (MRI) compared to histopathological diagnosis to distinguish between benign and malignant ovarian masses. Methods:The present cross-sectional study, which was conducted between 2021 and 2022, included a cohort of women with ovarian mass. Gyneco-oncologists referred all patients to the MRI center. The imaging protocol encompassed T1 and T2 weighted images, T1 fat-suppressed sequence, post-contrast and diffusion-weighted images (DWI). After surgery, the histopathological results were compared to the MRI diagnosis. Statistical analysis was done by using SPSS v.25 software. Results:A total of 67 women aged 15-82 years old were included in this study. Compared to histopathological diagnosis, MRI had a sensitivity of 96%, a specificity of 69%, a positive predictive value of 64.9% and a negative predictive value of 96.7%. Among patients under 40 years old, MRI showed a sensitivity of 100%, a specificity of 76.2%, a positive predictive value of 72.2% and a negative predictive value of 100%. Solid component and contrast enhancement within the solid component was significantly more frequent in patients with malignant diagnoses than those with benign masses (p<0.05). Conclusion:According to the results of the study, MRI is valuable for discriminating between benign and malignant ovarian masses, especially in patients under 40.

导言和目的:卵巢癌是女性的一种常见肿瘤。早期诊断对改善患者预后至关重要。本研究旨在确定磁共振成像(MRI)与组织病理学诊断相比在区分良性和恶性卵巢肿块方面的诊断价值。方法:本横断面研究于 2021 年至 2022 年间进行,纳入了一批患有卵巢肿块的妇女。妇科肿瘤专家将所有患者转诊至磁共振成像中心。成像方案包括T1和T2加权成像、T1脂肪抑制序列、对比后成像和弥散加权成像(DWI)。手术后,组织病理学结果与核磁共振诊断结果进行比较。统计分析采用 SPSS v.25 软件进行。结果:本研究共纳入 67 名 15-82 岁的女性。与组织病理学诊断相比,核磁共振成像的敏感性为96%,特异性为69%,阳性预测值为64.9%,阴性预测值为96.7%。在 40 岁以下的患者中,核磁共振成像的敏感性为 100%,特异性为 76.2%,阳性预测值为 72.2%,阴性预测值为 100%。确诊为恶性肿瘤的患者中,实性成分和实性成分内的对比增强明显多于良性肿块患者(p 结论:根据研究结果,核磁共振成像对区分良性和恶性卵巢肿块很有价值,尤其是对 40 岁以下的患者。
{"title":"Diagnostic Value of MRI Compared to Histopathological Results in Differentiating Benign from Malignant Ovarian Masses.","authors":"Azamsadat Jalili, Narges Afzali","doi":"10.26574/maedica.2024.19.1.4","DOIUrl":"10.26574/maedica.2024.19.1.4","url":null,"abstract":"<p><p><b>Introduction and aim:</b> Ovarian cancer is a prevalent neoplastic condition among females. Early diagnosis is essential in improving patient outcomes. This study aimed to determine the diagnostic value of magnetic resonance imaging (MRI) compared to histopathological diagnosis to distinguish between benign and malignant ovarian masses. <b>Methods:</b>The present cross-sectional study, which was conducted between 2021 and 2022, included a cohort of women with ovarian mass. Gyneco-oncologists referred all patients to the MRI center. The imaging protocol encompassed T1 and T2 weighted images, T1 fat-suppressed sequence, post-contrast and diffusion-weighted images (DWI). After surgery, the histopathological results were compared to the MRI diagnosis. Statistical analysis was done by using SPSS v.25 software. <b>Results:</b>A total of 67 women aged 15-82 years old were included in this study. Compared to histopathological diagnosis, MRI had a sensitivity of 96%, a specificity of 69%, a positive predictive value of 64.9% and a negative predictive value of 96.7%. Among patients under 40 years old, MRI showed a sensitivity of 100%, a specificity of 76.2%, a positive predictive value of 72.2% and a negative predictive value of 100%. Solid component and contrast enhancement within the solid component was significantly more frequent in patients with malignant diagnoses than those with benign masses (p<0.05). <b>Conclusion:</b>According to the results of the study, MRI is valuable for discriminating between benign and malignant ovarian masses, especially in patients under 40.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11079753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140913040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maedica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1